Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?
Ko H, Previs RA, Strickland KC, Klein J, Caveney B, Chiruzzi C, Eisenberg M, Severson EA, Ramkissoon S, Saini KS. Ko H, et al. Among authors: ramkissoon s. Oncol Ther. 2024 Mar;12(1):13-17. doi: 10.1007/s40487-023-00249-0. Epub 2023 Nov 14. Oncol Ther. 2024. PMID: 37962832 Free PMC article. No abstract available.
RNA Sequencing Identifies Novel NRG1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic Drivers.
Severson E, Achyut BR, Nesline M, Pabla S, Previs RA, Kannan G, Chenn A, Zhang S, Klein R, Conroy J, Sausen M, Sathyan P, Saini KS, Ghosh A, Jensen TJ, Reddy P, Ramkissoon SH. Severson E, et al. Among authors: ramkissoon sh. J Mol Diagn. 2023 Jul;25(7):454-466. doi: 10.1016/j.jmoldx.2023.03.011. Epub 2023 May 8. J Mol Diagn. 2023. PMID: 37164276 Free article.
Diversity and transparency in gynecologic oncology clinical trials.
Montes de Oca MK, Howell EP, Spinosa D, Knochenhauer H, Peipert BJ, Severson E, Ramkissoon S, Akinyemiju TF, Previs RA. Montes de Oca MK, et al. Among authors: ramkissoon s. Cancer Causes Control. 2023 Feb;34(2):133-140. doi: 10.1007/s10552-022-01646-y. Epub 2022 Oct 25. Cancer Causes Control. 2023. PMID: 36284031
PD-L1 Expression by RNA-Sequencing in Non-Small Cell Lung Cancer: Concordance with Immunohistochemistry and Associations with Pembrolizumab Treatment Outcomes.
Nesline MK, Previs RA, Dy GK, Deng L, Lee YH, DePietro P, Zhang S, Meyers N, Severson E, Ramkissoon S, Pabla S, Conroy JM. Nesline MK, et al. Among authors: ramkissoon s. Cancers (Basel). 2023 Sep 29;15(19):4789. doi: 10.3390/cancers15194789. Cancers (Basel). 2023. PMID: 37835483 Free PMC article.
Clinical characterization of the mutational landscape of 24,639 real-world samples from patients with myeloid malignancies.
Hogg G, Severson EA, Cai L, Hoffmann HM, Holden KA, Fitzgerald K, Kenyon A, Zeng Q, Mooney M, Gardner S, Chen W, Nagan N, Boles D, Parker S, Richman TJ, Letovsky S, Dong H, Anderson SM, Ramkissoon S, Reddy P, Eisenberg M, Chenn A, Jensen TJ. Hogg G, et al. Among authors: ramkissoon s. Cancer Genet. 2023 Nov;278-279:38-49. doi: 10.1016/j.cancergen.2023.07.006. Epub 2023 Aug 8. Cancer Genet. 2023. PMID: 37586297 Free article.
Validation of the Labcorp Plasma Focus Test to Facilitate Precision Oncology Through Cell-Free DNA Genomic Profiling of Solid Tumors.
Verner EL, Jackson JB, Severson E, Valkenburg KC, Greer AE, Riley DR, Sausen M, Maddox C, McGregor PM 3rd, Karandikar A, Hastings SB, Previs RA, Reddy VP, Jensen TJ, Ramkissoon SH. Verner EL, et al. J Mol Diagn. 2023 Jul;25(7):477-489. doi: 10.1016/j.jmoldx.2023.03.008. Epub 2023 Apr 15. J Mol Diagn. 2023. PMID: 37068734 Free article.
Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition.
Severson EA, Haberberger J, Hemmerich A, Huang RSP, Edgerly C, Schiavone K, Najafian A, Hiemenz M, Lechpammer M, Vergilio JA, Lesser G, Strowd R, Elvin J, Ross JS, Hegde P, Alexander B, Singer S, Ramkissoon S. Severson EA, et al. Among authors: ramkissoon s. Oncologist. 2023 Jan 18;28(1):e26-e35. doi: 10.1093/oncolo/oyac190. Oncologist. 2023. PMID: 36342081 Free PMC article.
POU2AF3-rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2.
Hiemenz MC, Kaur J, Kuang Z, Huang RSP, Harries L, Metzger D, Schiavone K, Millis SZ, Lin DI, Lechpammer M, Decker B, Mata DA, Reddy A, Parke M, Lee EY, Cui X, Iwenofu OH, Buehler D, Henderson L, Baldwin EM, Boikos SA, Ramkissoon SH, Smith SC. Hiemenz MC, et al. Among authors: ramkissoon sh. Genes Chromosomes Cancer. 2023 Aug;62(8):460-470. doi: 10.1002/gcc.23136. Epub 2023 Mar 31. Genes Chromosomes Cancer. 2023. PMID: 36862145
185 results